Medicine and Dentistry
Radioembolization
100%
Hepatocellular Carcinoma
98%
Yttrium 90
79%
Neoplasm
32%
Transcatheter Arterial Chemoembolization
29%
Overall Survival
27%
Microsphere
24%
Interventional Radiology
21%
Diseases
20%
Cancer
20%
Embolization
19%
Endoscopy
17%
Adverse Event
14%
Metastatic Carcinoma
14%
Liver Cancer
13%
Liver Transplantation
13%
Portal Vein Thrombosis
12%
Interventional Radiologist
12%
Oncology
12%
Bilirubin
12%
Hepatic Portal Vein
11%
Segmentectomy
11%
Lobectomy
10%
Necrosis
10%
Cholestasis
10%
Alpha-Fetoprotein
9%
Biliary Tract Drainage
8%
Systemic Therapy
8%
Hazard Ratio
8%
Pulmonary Shunt
8%
Liver Tumor
7%
Liver Metastasis
7%
Cholangiocarcinoma
7%
Albumin
7%
Response Evaluation Criteria in Solid Tumors
7%
Quality of Life
6%
Transjugular Intrahepatic Portosystemic Shunt
6%
Multivariate Analysis
6%
Radiofrequency Ablation
6%
Liver Function
6%
Stenting
5%
Congenital Malformation
5%
Biliary Tract Disease
5%
Retrospective Study
5%
Colorectal Carcinoma
5%
Cholecystostomy
5%
Survival Analysis
5%
Keyphrases
Hepatocellular Carcinoma
80%
Radioembolization
77%
Yttrium-90 Radioembolization
45%
Chemoembolization
24%
Locoregional Therapy
23%
Overall Survival
20%
Interventional Radiology
20%
Yttrium-90 Microspheres
17%
Transarterial Radioembolization
16%
Yttrium-90
16%
Patient Cohort
14%
Portal Vein Thrombosis
14%
Hepatocellular Carcinoma Patients
13%
Liver
13%
Tumor
13%
Liver Transplantation
13%
Transarterial Chemoembolization
13%
Confidence Interval
12%
Adverse Events
12%
Radiation Segmentectomy
12%
Interventional Radiologist
11%
European Association for the Study of the Liver
11%
Alpha-fetoprotein
10%
Radiation Lobectomy
10%
Necrosis
10%
Time to Progression
9%
Endoscopy
9%
Resection
9%
Embolization
8%
Intra-arterial
8%
Hepatic Malignancy
8%
Hazard Ratio
8%
Metastasis
8%
Lung Shunt Fraction
8%
Liver Malignancy
8%
Median Overall Survival
8%
Interventional Oncology
7%
World Health Organization
7%
Transarterial
7%
Imaging Response
7%
Systemic Therapy
7%
Portal Vein
7%
Barcelona Clinic Liver Cancer
7%
Multivariate Analysis
7%
Primary Liver Cancer
6%
Transjugular Intrahepatic Portosystemic Shunt
6%
Endoscopic Surgery
6%
Response Evaluation Criteria in Solid Tumors (RECIST)
6%
Percutaneous Biliary Intervention
6%
Image-guided
6%